m+Medelevator.RU
← Поиск публикаций
The journal of vascular access · 2025

Ultrasound-guided Femoseal® vascular closure device in antegrade common femoral artery puncture.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Oddi Fabio Massimo, Fresilli Mauro, Pennetta Federico Francisco, Micali Rosario, Ascoli Marchetti Andrea, Ippoliti Arnaldo

Аннотация

AIM: To retrospectively review the efficacy and safety of ultrasound-guided Femoseal vascular closure device in antegrade common femoral artery puncture after peripheral arteries revascularization.

METHODS: We reviewed the hemostatic outcome achieved with DUS guided FemoSeal in patients undergoing antegrade common femoral artery accesses for percutaneous lower limbs revascularization using 6- to 8-Fr vascular sheaths. Exclusion criteria were known bleeding or coagulation disorder, previous femoral artery punctures within 1 month and/or previous common femoral artery vascular interventions. Primary endpoint was technical success. Secondary endpoints were access complications and need for reintervention.

RESULTS: A total of 301 patients (250 M; 51 F) were included in the study. Technical success was achieved in 99%. One pseudoaneurysm (0.3%) developed in the first post-operative day and was treated with Human Thrombin Injection. Two more pseudoaneurysms were found during follow-up at the first 1 month US scan. Two conversions to manual compression occurred.

CONCLUSION: The use of ultrasound-guided FemoSeal VCD in antegrade CFA puncture demonstrated high technical success and a low complication rate. These findings suggest that it is a safe and effective option for achieving hemostasis in patients undergoing percutaneous lower limb revascularization. Further studies with larger cohorts and longer follow-up may help confirm these results and refine patient selection criteria.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты